United Kingdom· GB-APID-43793611000001106
Ayvakyt 50mg tablets
A avapritinib product containing avapritinib, registered in United Kingdom by Blueprint Medicines (UK) Ltd. The same ATC class is registered in 14 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Avapritinib is registered in 14 of 19 countries.
Countries holding a registration under ATC L01EX18 (avapritinib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Avapritinib · ATC L01EX18
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of avapritinib costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Avapritinib · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- FR France$1.93
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Avapritinib
- Manufacturer
- Blueprint Medicines (UK) Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01EX18
- ATC class
- Avapritinib
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin08720165565306
- gtin8720165565306
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
226 interactions on record for avapritinib.
Graded by severity as the source publishes them — 142 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Avapritinib · interactions on record
226 records
- 142 severe
- 84 moderate
Most severe, free to view
- AprepitantA04AD12severe
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- HeparinB01AB01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Avapritinib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaAYVAKYTBLUEPRINT MEDICINES CORPORATION
- United StatesAyvakitBlueprint Medicines Corporation
- SwitzerlandAyvakyt 100 mg, FilmtablettenBlueprint Medicines (Switzerland) GmbH
- CzechiaAYVAKYTBlueprint Medicines (Netherlands) B.V., Amsterdam
- SpainAYVAKYT 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULABlueprint Medicines (Netherlands) B.V.
- FinlandAYVAKYTBlueprint Medicines Netherlands B.V.
- FranceAYVAKYT 100 mg, comprimé pelliculéBLUEPRINT MEDICINES (PAYS-BAS))
- BelgiumAyvakyt 100 mgBlueprint Medicines (Netherlands)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ayvakyt
- Liechtenstein · Ayvakyt
- Norway · Ayvakyt
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d9beec19-33d9-4fca-8bd6-c3a6b0cc2ea5 GET /v1/drugs/d9beec19-33d9-4fca-8bd6-c3a6b0cc2ea5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "43793611000001106",
"desc": "Ayvakyt 50mg tablets (Blueprint Medicines (UK) Ltd)",
"form": "Oral tablet",
"vpid": "43989711000001105",
"source": "dmd",
"vtm_id": "838471001",
"strength": "50 mg",
"substance": "Avapritinib",
"ingredient": "Avapritinib",
"supplier_code": "39059811000001100"
}See everything about avapritinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.